Alethia Young
CIK: 0001918147
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jun 10, 2026PCRX
Pacira BioSciences, Inc.
Award(A)Direct6.4K shares- - Jan 5, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct1.9K shares at avg. $6.54$12K - Jan 5, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct2.5K shares at avg. $6.45$16K - Jan 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct3.3K shares at avg. $6.80$22K - Jan 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Award(A)Direct50K shares- - Jan 2, 2026PTCT
PTC THERAPEUTICS, INC.
Award(A)Direct4K shares- - Oct 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct217 shares at avg. $8.40$2K - Oct 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct265 shares at avg. $8.61$2K - Jul 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct204 shares at avg. $7.09$1K - Jun 11, 2025PCRX
Pacira BioSciences, Inc.
Award(A)Direct6.2K shares- - Apr 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct215 shares at avg. $8.02$2K - Jan 3, 2025PTCT
PTC THERAPEUTICS, INC.
Award(A)Direct4K shares- - Jan 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Award(A)Direct35K shares- - Jan 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct1.4K shares at avg. $14.09$20K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  PCRX Pacira BioSciences, Inc. | Award(A) | 6,405 | - | $0 | Direct |
| Jan 5, 2026 |  BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 1,878 | $6.54 | $12,282 | Direct |
| Jan 5, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 2,456 | $6.45 | $15,841 | Direct |
| Jan 2, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 3,289 | $6.80 | $22,365 | Direct |
| Jan 2, 2026 | BCYC BICYCLE THERAPEUTICS PLC | Award(A) | 50,000 | - | $0 | Direct |
| Jan 2, 2026 |  PTCT PTC THERAPEUTICS, INC. | Award(A) | 4,000 | - | $0 | Direct |
| Oct 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 217 | $8.40 | $1,823 | Direct |
| Oct 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 265 | $8.61 | $2,280 | Direct |
| Jul 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 204 | $7.09 | $1,446 | Direct |
| Jun 11, 2025 | PCRX Pacira BioSciences, Inc. | Award(A) | 6,163 | - | - | Direct |
| Apr 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 215 | $8.02 | $1,724 | Direct |
| Jan 3, 2025 | PTCT PTC THERAPEUTICS, INC. | Award(A) | 4,000 | - | $0 | Direct |
| Jan 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Award(A) | 35,000 | - | $0 | Direct |
| Jan 2, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Sale(S) | 1,395 | $14.09 | $19,656 | Direct |
1-14 of 14 transactions
About Young Alethia
Young Alethia (SEC CIK 0001918147) files insider reports with the SEC as Director of Pacira BioSciences, Inc. (PCRX), Chief Financial Officer of BICYCLE THERAPEUTICS PLC (BCYC) and Director of PTC THERAPEUTICS, INC. (PTCT).
Signal8 holds 9 ownership filings by Young Alethia, all Form 4s, filed between Jan 6, 2025 and Jun 12, 2026. Those filings report 14 transactions, from Jan 2, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Young Alethia's filings is in BRISBANE, CA.
Recent filings by Young Alethia
- Jun 10, 2026: Grant or award of PCRX shares (Form 4, code A).
- Jan 5, 2026: Open-market sales of BCYC shares (2 lines, Form 4, code S).
- Jan 2, 2026: Open-market sale of BCYC shares (Form 4, code S).
- Jan 2, 2026: Grant or award of BCYC shares (Form 4, code A).
- Jan 2, 2026: Grant or award of PTCT shares (Form 4, code A).
Other insiders filing for Pacira BioSciences, Inc. (PCRX)
- RIKER LAUREN, Senior Vice President, Finance
- SLONIN JONATHAN, Chief Medical Officer
- Hirawat Samit, Director
- CHRISTIE CHRISTOPHER, Director
- WIGGANS THOMAS G, Director
- YANG MICHAEL J., Director